Related Experiment Video
Updated: Apr 18, 2026

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Platelet-derived chemokines in atherosclerosis
J Duchene1, P von Hundelshausen
1Dr. Johan Duchene, Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Pettenkoferstr. 8a, 80336 München, Germany, Tel. 089/440 05-46 71; Fax -43 52,
Insights
Platelets release inflammatory chemokines that recruit leukocytes, driving atherosclerosis development. This review explores platelet-derived chemokines
Area of Science:
- Cardiovascular Biology
- Immunology
- Inflammation Research
Background:
- Activated platelets contribute to thrombotic events and atherosclerotic lesion development.
- Platelets release pro-inflammatory mediators, including chemokines, upon activation.
Purpose of the Study:
- To review recent findings on the roles of platelet-derived chemokines.
- To elucidate the effects of these chemokines on leukocyte recruitment and function in atherosclerosis.
Main Methods:
- Literature review of current research on platelet function and chemokines in atherosclerosis.
- Analysis of studies investigating chemokine signaling pathways and leukocyte interactions.
Main Results:
- Platelet-derived chemokines are crucial for recruiting leukocytes to atherosclerotic lesions.
- These chemokines influence leukocyte activation, differentiation, proliferation, and apoptosis.
- Specific chemokines released by platelets have distinct effects on inflammatory processes.
Conclusions:
- Platelet chemokines are key mediators in the inflammatory aspects of atherosclerosis.
- Targeting platelet-derived chemokines may offer novel therapeutic strategies for atherosclerosis.
Abstract:
In atherosclerosis, activated platelets have been recently recognised not only to participate in thrombotic events but also to play an essential role in the development of atherosclerotic lesions. Upon their activation, platelets release several pro-inflammatory mediators including chemokines. Chemokines are key molecules in inflammation as they are able to recruit leukocytes, modulate their activation/differentiation and control their proliferation/apoptosis. In this review we will discuss recent findings regarding the specific roles of chemokines released by platelets on leukocytes and their effects on atherosclerosis.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Inflammation
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Peripheral Artery Disease I: Introduction
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

